These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 8869044)

  • 21. Cancer screening for the primary care physician.
    Ashkar K; Bulbul M; Sharara A; Hourani M; Hamadeh GN
    J Med Liban; 2001; 49(5):298-302. PubMed ID: 12243426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitude of women towards early cancer detection and estimation of the compliance to a screening program for cervix and breast cancer.
    Bonelli L; Branca M; Ferreri M; Barizzone D; Rossi E; Cedri S; Bruzzi P; Santi L
    Cancer Detect Prev; 1996; 20(4):342-52. PubMed ID: 8818395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer occurrence and screening in family practice. A 20-year experience.
    Kiernan GN; Frame PS
    J Fam Pract; 1996 Jul; 43(1):49-55. PubMed ID: 8691180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for cancer--a current health service? An updating of screening for breast cancer, cervix cancer and colorectal cancer].
    Hoff G
    Tidsskr Nor Laegeforen; 1987 Aug; 107(23):1864-8. PubMed ID: 3660367
    [No Abstract]   [Full Text] [Related]  

  • 25. Update: National Breast and Cervical Cancer Early Detection Program--July 1991-September 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(23):484-7. PubMed ID: 8628207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.
    Coughlin SS; Thompson TD; Hall HI; Logan P; Uhler RJ
    Cancer; 2002 Jun; 94(11):2801-12. PubMed ID: 12115366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance with referrals from a cancer-screening project.
    Lane DS
    J Fam Pract; 1983 Nov; 17(5):811-7. PubMed ID: 6631345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distribution of West Virginia women targeted for screening of breast and cervical cancers.
    German RR
    W V Med J; 1996; 92(2):82-6. PubMed ID: 8857175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten years of screening for cancer in a family practice.
    Berner JS; Frame PS; Dickinson JC
    J Fam Pract; 1987 Mar; 24(3):249-52. PubMed ID: 3819663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
    Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
    Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in Mumbai, India. 1. Compliance to screening.
    Dinshaw K; Mishra G; Shastri S; Badwe R; Kerkar R; Ramani S; Thakur M; Uplap P; Kakade A; Gupta S; Ganesh B
    Oncology; 2007; 73(3-4):145-53. PubMed ID: 18408401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
    Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
    Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
    Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Colonic and rectal cancer screening using fecal occult blood analysis (our experience)].
    Trignano M; Uzzau A; Nonnis R; Terrosu G; Noce L; Farris A
    Chir Ital; 1986 Oct; 38(5):511-8. PubMed ID: 3815641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mass screening for breast cancer in Herault county. First results in women between 40 and 70 years old].
    Daures JP; Peray P; Bousquet J; Stoebner A; Gouzes C; Lamarque JL; Laurent JC; Cherif Cheikh J; Boulet P; Pujol J
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):173-8. PubMed ID: 1583294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast and cervical cancer screening in the 90's.
    Deloney L
    J Ark Med Soc; 1994 Oct; 91(5):236-8. PubMed ID: 7961312
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
    Buki LP; Jamison J; Anderson CJ; Cuadra AM
    Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.